4 results on '"Solomon Sava"'
Search Results
2. Leading causes of death and high mortality rates in an HIV endemic setting (Kisumu county, Kenya, 2019).
- Author
-
Anthony Waruru, Dickens Onyango, Lilly Nyagah, Alex Sila, Wanjiru Waruiru, Solomon Sava, Elizabeth Oele, Emmanuel Nyakeriga, Sheru W Muuo, Jacqueline Kiboye, Paul K Musingila, Marianne A B van der Sande, Thaddeus Massawa, Emily A Rogena, Kevin M DeCock, and Peter W Young
- Subjects
Medicine ,Science - Abstract
BackgroundIn resource-limited settings, underlying causes of death (UCOD) often are not ascertained systematically, leading to unreliable mortality statistics. We reviewed medical charts to establish UCOD for decedents at two high volume mortuaries in Kisumu County, Kenya, and compared ascertained UCOD to those notified to the civil registry.MethodsMedical experts trained in COD certification examined medical charts and ascertained causes of death for 456 decedents admitted to the mortuaries from April 16 through July 12, 2019. Decedents with unknown HIV status or who had tested HIV-negative >90 days before the date of death were tested for HIV. We calculated annualized all-cause and cause-specific mortality rates grouped according to global burden of disease (GBD) categories and separately for deaths due to HIV/AIDS and expressed estimated deaths per 100,000 population. We compared notified to ascertained UCOD using Cohen's Kappa (κ) and assessed for the independence of proportions using Pearson's chi-squared test.FindingsThe four leading UCOD were HIV/AIDS (102/442 [23.1%]), hypertensive disease (41/442 [9.3%]), other cardiovascular diseases (23/442 [5.2%]), and cancer (20/442 [4.5%]). The all-cause mortality rate was 1,086/100,000 population. The highest cause-specific mortality was in GBD category II (noncommunicable diseases; 516/100,000), followed by GBD I (communicable, perinatal, maternal, and nutritional; 513/100,000), and III (injuries; 56/100,000). The HIV/AIDS mortality rate was 251/100,000 population. The proportion of deaths due to GBD II causes was higher among females (51.9%) than male decedents (42.1%; p = 0.039). Conversely, more men/boys (8.6%) than women/girls (2.1%) died of GBD III causes (p = 0.002). Most of the records with available recorded and ascertained UCOD (n = 236), 167 (70.8%) had incorrectly recorded UCOD, and agreement between notified and ascertained UCOD was poor (29.2%; κ = 0.26).ConclusionsMortality from infectious diseases, especially HIV/AIDS, is high in Kisumu County, but there is a shift toward higher mortality from noncommunicable diseases, possibly reflecting an epidemiologic transition and improving HIV outcomes. The epidemiologic transition suggests the need for increased focus on controlling noncommunicable conditions despite the high communicable disease burden. The weak agreement between notified and ascertained UCOD could lead to substantial inaccuracies in mortality statistics, which wholly depend on death notifications.
- Published
- 2022
- Full Text
- View/download PDF
3. Evaluation of the Performance of OraQuick Rapid HIV-1/2 Test Among Decedents in Kisumu, Kenya
- Author
-
Macxine Oguta, Paul Musingila, Peter Young, Mary Mwangome, Leonard Kingwara, Solomon Sava, Frankline O. Mboya, Boaz Oyaro, Alex Sila, Anthony Waruru, Valarie Opollo, Emmanuel Nyakeriga, Lilly M. Nyagah, Catherine Ngugi, Muthoni Junghae, Wanjiru Waruiru, and Dickens Onyango
- Subjects
medicine.medical_specialty ,Population ,Human immunodeficiency virus (HIV) ,HIV Infections ,Hiv testing ,HIV Antibodies ,medicine.disease_cause ,Sensitivity and Specificity ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,parasitic diseases ,Medicine ,Humans ,Pharmacology (medical) ,education ,education.field_of_study ,business.industry ,Infant ,Gold standard (test) ,medicine.disease ,Kenya ,Confidence interval ,Test (assessment) ,Infectious Diseases ,HIV-1 ,Oral fluid ,Reagent Kits, Diagnostic ,business - Abstract
Estimating cause-related mortality among the dead is not common, yet for clinical and public health purposes, a lot can be learnt from the dead. HIV/AIDS accounted for the third most frequent cause of deaths in Kenya; 39.7 deaths per 100,000 population in 2019. OraQuick Rapid HIV-1/2 has previously been validated on oral fluid and implemented as a screening assay for HIV self-testing in Kenya among living subjects. We assessed the feasibility and diagnostic accuracy of OraQuick Rapid HIV-1/2 for HIV screening among decedents.Trained morticians collected oral fluid from 132 preembalmed and postembalmed decedents aged18 months at Jaramogi Oginga Odinga Teaching and Referral Hospital mortuary in western Kenya and tested for HIV using OraQuick Rapid HIV-1/2. Test results were compared with those obtained using the national HIV Testing Services algorithm on matched preembalming whole blood specimens as a gold standard (Determine HIV and First Response HIV 1-2-O). We calculated positive predictive values, negative predictive values, area under the curve, and sensitivity and specificity of OraQuick Rapid HIV-1/2 compared with the national HTS algorithm.OraQuick Rapid HIV-1/2 had similar sensitivity of 92.6% [95% confidence interval (CI): 75.7 to 99.1] on preembalmed and postembalmed samples compared with the gold standard. Specificity was 97.1% (95% CI: 91.9 to 99.4) and 95.2% (95% CI: 89.2 to 98.4) preembalming and postembalming, respectively. Preembalming and postembalming positive predictive value was 89.3% (95% CI: 71.8 to 97.7) and 83.3% (95% CI: 65.3 to 94.4), respectively. The area under the curve preembalming and postembalming was 94.9% (95% CI: 89.6 to 100) and 93.9% (95% CI: 88.5 to 99.4), respectively.The study showed a relatively high-performance sensitivity and specificity of OraQuick Rapid HIV-1/2 test among decedents, similar to those observed among living subjects. OraQuick Rapid HIV-1/2 presents a convenient and less invasive screening test for surveillance of HIV among decedents within a mortuary setting.
- Published
- 2021
4. Pathology and telepathology methods in the child health and mortality prevention surveillance network
- Author
-
Carla Carrilho, Cheick Boudadari Traore, Jana M. Ritter, Farida Arjuman, Wun-Ju Shieh, Benjamin Esiaba Ndibile, Jaume Ordi, Solomon Sava, Roosecelis B Martines, Joy Gary, Dianna M. Blau, Sherif R. Zaki, Mohammad Mosiur Rahman, Mohammed Kamal, Mamudo R. Ismail, and Martin Hale
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Telepathology ,Infant mortality ,Child health ,Specimen Handling ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Pathology ,Humans ,Medical physics ,030212 general & internal medicine ,Medical diagnosis ,Child ,Children ,business.industry ,Child Health ,Tissue sampling ,Disease control ,Patologia ,Infectious Diseases ,Population Surveillance ,030220 oncology & carcinogenesis ,Child Mortality ,Pathology laboratory ,Autòpsia ,Autopsy ,business ,Early phase ,Infants ,human activities ,Network approach ,Mortalitat infantil - Abstract
This manuscript describes the Child Health and Mortality Prevention Surveillance (CHAMPS) network approach to pathologic evaluation of minimally invasive tissue sampling (MITS) specimens, including guidelines for histopathologic examination and further diagnostics with special stains, immunohistochemistry, and molecular testing, as performed at the CHAMPS Central Pathology Laboratory (CPL) at the Centers for Disease Control and Prevention, as well as techniques for virtual discussion of these cases (telepathology) with CHAMPS surveillance locations. Based on review of MITS from the early phase of CHAMPS, the CPL has developed standardized histopathology-based algorithms for achieving diagnoses from MITS and telepathology procedures in conjunction with the CHAMPS sites, with the use of whole slide scanners and digital image archives, for maximizing concurrence and knowledge sharing between site and CPL pathologists. These algorithms and procedures, along with lessons learned from initial implementation of these approaches, guide pathologists at the CPL and CHAMPS sites through standardized diagnostics of MITS cases, and allow for productive, real-time case discussions and consultations.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.